These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 16400902

  • 1. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
    Meltzer EO, Hampel FC, Ratner PH, Bernstein DI, Larsen LV, Berger WE, Finn AF, Marple BF, Roland PS, Wall GM, Brubaker MJ, Dimas C, Potts SL, Silver LH, Barnes JR.
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):600-6. PubMed ID: 16400902
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.
    Ratner PH, Hampel FC, Amar NJ, van Bavel JH, Mohar D, Marple BF, Roland PS, Wall GM, Brubaker MJ, Drake M, Turner D, Silver LH.
    Ann Allergy Asthma Immunol; 2005 Nov; 95(5):474-9. PubMed ID: 16312171
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 4. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G.
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [Abstract] [Full Text] [Related]

  • 5. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO.
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E.
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF, Corren J, Wheeler WJ, Berger WE, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
    Lumry W, Prenner B, Corren J, Wheeler W.
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331
    [Abstract] [Full Text] [Related]

  • 9. An assessment of the onset and duration of action of olopatadine nasal spray.
    Patel P, Roland PS, Marple BF, Benninger PJ, Margalias H, Brubaker M, Beezley SF, Drake M, Potts SL, Wall GM.
    Otolaryngol Head Neck Surg; 2007 Dec; 137(6):918-24. PubMed ID: 18036421
    [Abstract] [Full Text] [Related]

  • 10. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
    Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Turner FD, Wells DT, Robertson SM.
    Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
    [Abstract] [Full Text] [Related]

  • 11. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
    Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C, Faris MA, Ellsworth A, Caldwell MF.
    Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [Abstract] [Full Text] [Related]

  • 13. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.
    Kaliner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, Lanier BQ, Chipps B.
    Allergy Asthma Proc; 2009 Jan; 30(3):255-62. PubMed ID: 19549426
    [Abstract] [Full Text] [Related]

  • 14. Olopatadine hydrochloride in children: efficacy and safety for perennial allergic rhinitis.
    Okubo K, Okuda M, Magara H, Kaneko K.
    Curr Med Res Opin; 2010 Jul; 26(7):1657-65. PubMed ID: 20443650
    [Abstract] [Full Text] [Related]

  • 15. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
    Nathan RA, Berger W, Yang W, Cheema A, Silvey M, Wu W, Philpot E.
    Ann Allergy Asthma Immunol; 2008 May; 100(5):497-505. PubMed ID: 18517084
    [Abstract] [Full Text] [Related]

  • 16. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.
    Hampel FC, Ratner PH, Amar NJ, van Bavel JH, Mohar D, Fairchild CJ, Wall GM, Brubaker MJ, Drake M, Crenshaw KM.
    Allergy Asthma Proc; 2006 May; 27(3):202-7. PubMed ID: 16913262
    [Abstract] [Full Text] [Related]

  • 17. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate.
    Patel D, Garadi R, Brubaker M, Conroy JP, Kaji Y, Crenshaw K, Whitling A, Wall GM.
    Allergy Asthma Proc; 2007 May; 28(5):592-9. PubMed ID: 18034980
    [Abstract] [Full Text] [Related]

  • 18. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy.
    Berger W, Abelson MB, Gomes PJ, Beck M, Kimura S, Westbrook T, Storms W, Galant S.
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):361-71. PubMed ID: 16279567
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
    Yamamoto H, Yamada T, Kubo S, Osawa Y, Kimura Y, Oh M, Susuki D, Takabayashi T, Okamoto M, Fujieda S.
    Allergy Asthma Proc; 2010 Oct; 31(4):296-303. PubMed ID: 20819319
    [Abstract] [Full Text] [Related]

  • 20. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC, Ratner PH, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.